Skip to main content
Premium Trial:

Request an Annual Quote

Perhaps There Are Better Ways to Spend the Money

It's not just financial firms that are being looked at askance over the pay of executives and board members -- biotech companies are also feeling the heat, reports the Wall Street Journal. An article in the June issue of Nature Biotechnology analyzed the salaries of 51 UK biotech companies, finding the average compensation for a chief executive to be £297,947 (US$493,616), and noting that higher pay didn't necessarily track with better performance. "There are quite a number of companies paying really quite substantial sums to CEOs and board members when they have very poor prospects. It cannot be helpful for the companies to have people draining cash out of them in this way," says study author William Bains from the University of Cambridge.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.